Sponsor
Precision Medicine Sparks Personalized PMS Solutions
The global Premenstrual Syndrome (PMS) treatment market is projected to increase from USD 1.37 billion in 2022 to USD 1.83 billion by 2031, growing at a CAGR of 4.1%. This growth is fueled by expanding awareness, accessible over-the-counter (OTC) options, advances in hormonal therapy, and rising *** in digital health platforms targeting women’s reproductive health. Market Snapshot 2022...
0 Reacties 0 aandelen 2K Views 0 voorbeeld
Sponsor
Sponsor
Sponsor